Concepedia

Peter Mohr

PM

Statistics

Publications

16

Citations

827

H-Index

14

Active since

1967

Affiliations

Roche (Switzerland)(Current)

University of Basel

Array BioPharma (United States)

Peter Mohr is an author at Roche (Switzerland) specializing in pharmacology, medicinal chemistry, and molecular pharmacology.

Publications per year

1967–2023

16

Publications

16

A Study of Stereoselective Hydrolysis of Symmetrical Diesters with Pig Liver Esterase

Peter Mohr, N. WAESPE‐SARCEVIC, Christoph Tamm et al. · Helvetica Chimica Acta · 1983 · 199 citations

, , +13

Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes

Agnès Bénardeau, Jörg Benz, Alfred Binggeli et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 105 citations · Full text

, , +13

Enhancement of HL-60 Differentiation by a New Class of Retinoids with Selective Activity on Retinoid X Receptor

Christian Apfel, Markus Kamber, Michael Klaus et al. · Journal of Biological Chemistry · 1995 · 91 citations · Full text

, , +12

Structure-based design of indole propionic acids as novel PPARα/γ co-agonists

Bernd Kuhn, Hans Hilpert, Jörg Benz et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 71 citations · Full text

, , +12

Synthesis of Verrucarin A and 3α‐Hydroxyverrucarin A from Verrucarol and Diacetoxyscripenol (Anguidine). 39th Communication on Verrucarins and Roridins

Peter Mohr, Motoo Tori, Peter Grossen et al. · Helvetica Chimica Acta · 1982 · 49 citations

, , +2

1–5 of 16